Gunneflo Life Science AB
ActiveKey figures
Key figures
2025Summary: Gunneflo Life Science AB
What kind of company is it?
Gunneflo Life Science AB (org. no. 556687-9622) is a limited company (AB). The company was registered in 2005 and has existed for 21 years. Registered seat: Stockholm. Industry according to Statistics Sweden: business and other management consultancy activities (SNI 70200).
How is the company doing financially?
The company had no net sales in financial year 2025. Financial year 2025 ended with a loss of 169 106 kr. The company was profitable in 2 of the 3 reported financial years. At the end of financial year 2025, total assets were 3 286 228 kr and equity 3 271 228 kr (equity ratio 99,5 %). The annual report for 2025 proposes a dividend of 322 000 kr.
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 2 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 322 000 kr.
Summary of annual reports2023–2025
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Sales revenue | 0 | 0 | 0 |
| Profit for the reporting year | 169 769 | 293 216 | −169 106 |
| Retained earnings of previous periods | — | — | — |
| Total assets | 3 649 838 | 3 733 054 | 3 286 228 |
| Total liabilities | 88 720 | 82 720 | 15 000 |
| Total equity | 3 561 118 | 3 650 334 | 3 271 228 |
| Employees | — | — | — |
| Proposed dividend | — | 210 000 | 322 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.